Patrick F. Finn
Moderna Therapeutics (United States)(US)
Publications by Year
Research Areas
Lysosomal Storage Disorders Research, Metabolism and Genetic Disorders, Glycogen Storage Diseases and Myoclonus, Carbohydrate Chemistry and Synthesis, Amino Acid Enzymes and Metabolism
Most-Cited Works
- → Proteolytic and lipolytic responses to starvation(2006)320 cited
- → Systemic mRNA Therapy for the Treatment of Fabry Disease: Preclinical Studies in Wild-Type Mice, Fabry Mouse Model, and Wild-Type Non-human Primates(2019)157 cited
- → Effects of Small Molecules on Chaperone-Mediated Autophagy(2005)149 cited
- → Ketone Bodies Stimulate Chaperone-mediatedAutophagy(2005)138 cited
- → mRNA Therapy Improves Metabolic and Behavioral Abnormalities in a Murine Model of Citrin Deficiency(2019)72 cited
- → Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB/c.Abcb4 mouse model of PFIC3(2020)70 cited
- → mRNA therapy restores euglycemia and prevents liver tumors in murine model of glycogen storage disease(2021)66 cited
- → Inhibition of glycogen biosynthesis via mTORC1 suppression as an adjunct therapy for Pompe disease(2010)46 cited
- → Strategies for Neoglycan Conjugation to Human Acid α-Glucosidase(2011)44 cited
- → Characterizing the mechanism of action for mRNA therapeutics for the treatment of propionic acidemia, methylmalonic acidemia, and phenylketonuria(2024)42 cited